Directory
>
Robin Taylor
Robin Taylor
Chief Commercial Officer | Agenus
Lexington, Massachusetts, United States
Robin Taylor
Summary
Robin Taylor is a seasoned executive with extensive experience in the biopharmaceutical industry, currently serving as the Chief Commercial Officer at Agenus. With a strong background in clinical development and commercialization, Robin has successfully led cross-functional teams in launching innovative therapies in oncology and immunology. Robin holds a Ph.D. in Molecular Genetics and an MBA from UC Berkeley, showcasing a unique blend of scientific expertise and business acumen. Throughout their career, Robin has held leadership positions at prominent companies like Genentech and AstraZeneca, where they spearheaded strategic initiatives and product launches. Passionate about advancing personalized medicine, Robin is also an active member of the Scientific Advisory Board at Senti Biosciences. Their commitment to innovation and leadership in the life sciences sector is evident through their ongoing contributions to drug development and market access strategies.
Robin Taylor
Work Experience
Chief Commercial Officer at
Agenus
July 2023 - Present
Member, Scientific Advisory Board at
Senti Biosciences
August 2021 - Present
Owner at
Taylor Global Biopharma Consulting LLC
March 2020 - Present
Chief Commercial Officer at
Seagen
May 2019 - February 2020
Vice-President, Franchise Head, ImmunoOncology at
AstraZeneca
November 2018 - April 2019
Vice President, Cancer Immunotherapy Franchise Head at
Genentech Foundation
January 2016 - November 2018
Vice President, Lung and Cancer Immunotherapy Franchise Head, Global Product Strategy at
Genentech Foundation
May 2014 - December 2015
Lifecycle Leader, Onartuzumab (MetMAb) at
Genentech Foundation
December 2010 - April 2014
Senior Director, Oncology Pipeline Head, Global Product Strategy at
Genentech Foundation
October 2009 - February 2011
Director, BioOncology Pipeline Commercial Development at
Genentech Foundation
April 2007 - December 2009
Director, Avastin GI Cancers at
Genentech Foundation
July 2005 - March 2007
Group Product Manager, Avastin at
Genentech Foundation
February 2004 - June 2005
Senior Product Manager, Avastin at
Genentech Foundation
June 2003 - February 2004
Product Manager, Herceptin at
Genentech Foundation
May 2002 - June 2003
Associate Product Manager, Herceptin at
Genentech Foundation
August 2001 - April 2002
Sales Oncology Specialist, Herceptin at
Genentech Foundation
March 2001 - July 2001
Summer Intern, Rituxan & Herceptin at
Genentech Foundation
May 1999 - August 1999
Staff Scientist at
Mount Sinai Hospital Research Institute Toronto
January 1998 - July 1998
Postdoctoral Researcher, Neuroscience at
The National Institutes of Health
October 1995 - December 1997
Postdoctoral Researcher, Neuroscience at
University of California, San Francisco
June 1993 - October 1995
Robin Taylor
Education
January 1998 - January 2000
University of Toronto, Ph.D.
January 1985 - January 1993
The University of British Columbia, B.Sc.
January 1980 - January 1984
Frequently Asked Questions about Robin Taylor
What is Robin Taylor email address?
Robin Taylor's primary email address is ************@agenusbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Robin Taylor work for?
Robin Taylor is a Chief Commercial Officer at Agenus, a company specializing in Commercial physical research.
Where Robin Taylor graduated from?
Robin Taylor holds a degree in Finance, Marketing, Entrepreneurship from Haas School of Business.
How can I directly contact Robin Taylor?
To contact Robin Taylor directly, you can use the email address ************@agenusbio.com. Complete contact information is available upon registration with Muraena.
Who is Robin Taylor?
Robin Taylor is a seasoned executive with extensive experience in the biopharmaceutical industry, currently serving as the Chief Commercial Officer at Agenus. With a strong background in clinical development and commercialization, Robin has successfully led cross-functional teams in launching innovative therapies in oncology and immunology. Robin holds a Ph.D. in Molecular Genetics and an MBA from UC Berkeley, showcasing a unique blend of scientific expertise and business acumen. Throughout their career, Robin has held leadership positions at prominent companies like Genentech and AstraZeneca, where they spearheaded strategic initiatives and product launches. Passionate about advancing personalized medicine, Robin is also an active member of the Scientific Advisory Board at Senti Biosciences. Their commitment to innovation and leadership in the life sciences sector is evident through their ongoing contributions to drug development and market access strategies.
Robin`s contact details
************@agenusbio.com
********@alumni.haas.org
************@gene.com
Colleagues
Independent board member
Vice President, Commercial Operations and Business Analytics
Vice President, Technical Operations
Chief Medical Officer
Chief Quality Officer
Executive Director, Global Financial Operations
Chief Commercial Transactions Officer
Associate Vice President, Head of Global HEOR Medical Value Access
VP Molecular and Information Science
Vice President, Research